William Blair Investment Management LLC Increases Stock Position in Doximity, Inc. $DOCS

Key Points

• William Blair Investment Management LLC has increased its stake in Doximity, Inc. by 13.8%, now owning approximately 5.22 million shares valued at around $320 million.
• The stock has received varied ratings from analysts, with price targets ranging from $65.00 to $81.00, and an average consensus price target of $69.37.
• Insider trading activity includes significant sales by directors, with 37,000 shares sold in the last ninety days, equating to over $2.6 million in transactions.

William Blair Investment Management LLC raised its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 13.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,219,394 shares of the company's stock after buying an additional 634,927 shares during the period. Doximity comprises about 0.8% of William Blair Investment Management LLC's investment portfolio, making the stock its 19th biggest holding. William Blair Investment Management LLC owned approximately 2.78% of Doximity worth $320,158,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. VSM Wealth Advisory LLC bought a new position in Doximity in the 1st quarter worth $29,000. Allworth Financial LP raised its holdings in Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI bought a new position in Doximity in the 1st quarter worth $33,000. Spire Wealth Management raised its holdings in Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after purchasing an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group raised its holdings in Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after purchasing an additional 309 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

DOCS has been the subject of several research reports. Robert W. Baird upped their price objective on shares of Doximity from $75.00 to $80.00 and gave the stock an "outperform" rating in a report on Thursday, September 11th. Zacks Research lowered shares of Doximity from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Evercore ISI upped their price objective on shares of Doximity from $75.00 to $81.00 and gave the stock an "outperform" rating in a report on Wednesday, October 8th. Raymond James Financial set a $75.00 price objective on shares of Doximity in a report on Wednesday, September 10th. Finally, Piper Sandler increased their price target on shares of Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $69.37.

Doximity Price Performance

Shares of Doximity stock opened at $67.56 on Friday. The company has a 50-day moving average of $69.22 and a 200 day moving average of $61.25. The firm has a market cap of $12.65 billion, a price-to-earnings ratio of 67.56, a PEG ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 1 year low of $40.87 and a 1 year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The business's revenue for the quarter was up 15.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the completion of the sale, the director directly owned 3,221 shares in the company, valued at approximately $241,575. This trade represents a 86.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Regina M. Benjamin sold 5,000 shares of the firm's stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $70.84, for a total transaction of $354,200.00. Following the sale, the director owned 19,839 shares of the company's stock, valued at approximately $1,405,394.76. This represents a 20.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,000 shares of company stock worth $2,635,880. 31.30% of the stock is owned by corporate insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.